You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 497 PTT-4256 is a first-in-class small molecule inhibitor of GPR65 that counteracts the low pH-dependent immunosuppressive effects on immune cells and displays pronounced anti-tumor activity in mice

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
497 PTT-4256 is a first-in-class small molecule inhibitor of GPR65 that counteracts the low pH-dependent immunosuppressive effects on immune cells and displays pronounced anti-tumor activity in mice

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023256029
Dec 202395012
Jan 20244208
Feb 20247206
Mar 2024124024
Apr 2024248045
May 202484020
Jun 20247207
Jul 2024100017
Aug 2024100013
Sep 2024106015
Oct 2024258032
Nov 2024241026
Dec 2024174015
Jan 2025206031
Feb 2025104011
Mar 20251010
Apr 20250013
May 20250018
Jun 20250011
Total22830363